9 Meters Biopharma Inc. (NMTR)
NASDAQ: NMTR
· Real-Time Price · USD
0.07
-0.06 (-44.71%)
At close: Jul 25, 2023, 10:00 PM
9 Meters Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -43.44M | -42.02M | -40.84M | -45.66M | -42.73M | -36.76M | -31.97M | -24.74M | -61.32M |
Interest Income | 653.2K | 501.23K | 219.51K | 89.25K | 30.43K | 22.71K | 7.32K | 9.22K | 11.26K |
Pretax Income | -46.28M | -43.77M | -41.39M | -45.58M | -42.7M | -36.78M | -32.19M | -26.98M | -63.32M |
Net Income | -49.8M | -45.44M | -41.95M | -45.5M | -42.69M | -36.78M | -32.19M | -26.98M | -63.32M |
Selling & General & Admin | 11M | 11.01M | 11.58M | 11.55M | 10.45M | 9.66M | 8.45M | 7.95M | 11.06M |
Research & Development | 32.44M | 31.01M | 29.26M | 29.01M | 27.17M | 22M | 18.42M | 16.79M | 11.52M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 43.44M | 42.02M | 40.84M | 40.56M | 37.62M | 31.66M | 26.87M | 24.74M | 22.58M |
Interest Expense | 3.49M | 2.73M | 912.96K | 67.59K | 3.43K | 47.19K | 382.69K | 2.5M | 3.52M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 43.44M | 42.02M | 40.84M | 40.56M | 37.62M | 31.66M | 26.87M | 24.74M | 22.58M |
Income Tax Expense | 3.52M | 1.67M | 570.58K | -66.14K | 5.68K | 62.26K | 388.04K | 2.5M | 3.52M |
Shares Outstanding (Basic) | 13.59M | 12.96M | 12.96M | 12.95M | 12.91M | n/a | 12.71M | 12.48M | 10.56M |
Shares Outstanding (Diluted) | 13.59M | 12.96M | 12.96M | 12.95M | 12.91M | n/a | 12.71M | 12.48M | 10.56M |
EPS (Basic) | -3.79 | -3.51 | -2.5 | -2.79 | -2.6 | -2.23 | -2.23 | -2.35 | -13.04 |
EPS (Diluted) | -3.79 | -3.51 | -2.5 | -2.79 | -2.6 | -2.23 | -2.23 | -2.35 | -13.04 |
EBITDA | -42.78M | -41.51M | -40.61M | -40.46M | -37.58M | -31.63M | -26.86M | -24.72M | -22.56M |
EBIT | -42.8M | -41.03M | -30.92M | -35.95M | -33.14M | -27.18M | -649.92M | -642.59M | -677.92M |
Depreciation & Amortization | 661.43K | 509.75K | 218.69K | 86.79K | 20.9K | 7.57K | 6.26K | 12.08K | 14.32K |